UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 16, 2019

Accession Number:	0001193125-19-194006
Submission Type:	POS AM
CIK: 0001420565 Company Name: AILERON THERAPEUTICS INC File Number: 333-231143